Page last updated: 2024-10-31

nevirapine and Neoplasms

nevirapine has been researched along with Neoplasms in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moghadam, NH1
Salehzadeh, S1
Rakhtshah, J1
Tanzadehpanah, H1
Moghadam, AH1
Hajibabaei, F1
Sharifinia, S1
Asl, SS1
Saidijam, M1

Other Studies

1 other study available for nevirapine and Neoplasms

ArticleYear
Improving antiproliferative effect of the nevirapine on Hela cells by loading onto chitosan coated magnetic nanoparticles as a fully biocompatible nano drug carrier.
    International journal of biological macromolecules, 2018, Oct-15, Volume: 118, Issue:Pt A

    Topics: Antineoplastic Agents; Cell Proliferation; Chitosan; Coated Materials, Biocompatible; Drug Carriers;

2018